Modern Military, Workforce, Athletes, and Elderly All Need Wearable Chemosensors to Monitor Safety, Health, and Performance

Rhea-AI Summary

US Nuclear Corp. (OTCQB:UCLE) is partnering with Grapheton to develop advanced wearable chemosensors targeting the $30 billion global chemical sensor market. These sensors, crafted from a special glassy carbon material, promise longevity (up to 40 years) and resilience, making them ideal for industrial and military applications. They can monitor various health parameters including cortisol and glucose levels, aiding in real-time health and safety monitoring, particularly crucial during the COVID-19 pandemic. Grapheton’s strategy includes adapting these sensors for human use and forming a Scientific Advisory Board to explore market opportunities.

Positive

• Grapheton's chemosensors have a lifespan of over 40 years, significantly greater than traditional sensors.
• The global chemical sensor market is projected to reach $30 billion by 2023, presenting a lucrative opportunity.
• Real-time monitoring capabilities can enhance workplace safety, addressing costly occupational health issues that exceed $250 billion annually in the US.

Negative

• None.

LOS ANGELES, CA / ACCESSWIRE / February 23, 2021 / The need for wearable sensors that record real-time body signals and are optimized for use in industrial and military environments remains exceptionally strong. The critical requirements of these chemosensors are longevity and ruggedness, qualities that Grapheton's core technology is well suited for. Eyeing the growing global market for chemical sensors that is projected to be $30 billion by 2023, US Nuclear's (OTCQB:UCLE) partner Grapheton has developed novel chemosensors which can be integrated into a wearable device. These devices can be used to monitor the health, safety, and performance of individuals in real-time, reducing risk from things such as infectious diseases, heat stroke or cold exposure, psychological stress, exhaustion, unwanted effects from medicines, or other conditions impacting health.

Multiple sensors can be integrated into a single wearable device. Grapheton's chemosensors are made of a special glassy carbon (GC) material, which has many advantages over traditional thin-film sensors: they don't corrode and are designed to resist biofouling - lasting 40 years or more, can withstand electrical stimulation of more than 3.5 billion pulses compared to a mere 10's of million pulses of thin-film metal electrodes, are ideal for electrophysiology and electrochemical recordings as a biochemical sensor, and can be integrated into flexible substrates to provide a better fit, lessening the inflammatory reactive response. Some common chemicals sensed by glassy carbon include: cortisol (stress level monitoring), glucose, glutamate, and lactate (metabolism monitoring), Ca²⁺, Na⁺ - K (dehydration monitoring), dopamine and serotonin (neural chemistry monitoring), ascorbic acid, uric acid, urea, H₂O₂, pH, and steroid hormones.

The data collected from the GC chemosensors will be processed and analyzed to enable effective real-time decision making while providing an overview of both individual and team performance. The costs of occupational fatalities, illnesses, and injuries exceed $250 billion annually in the US alone and the COVID-19 pandemic has only exacerbated the situation. Grapheton's rugged GC chemosensors will provide reliable real-time monitoring, helping to improve workplace safety and worker health, as well as finding use in other applications such as monitoring the sick or elderly, high-performance athletes, or military personnel operating under difficult conditions in challenging environments.

Beginning in Q1 2021, Grapheton's plan is to identify use cases, analyze the existing wearables market, adapt GC chemosensors for human use, and design innovative wearables with integrated chemosensors.

The broader market for Grapheton's products is in implantable devices, biocompatible chips, wearable devices, on-chip supercapacitors, and on-chip thin-film transistors. Grapheton is currently assembling a Scientific Advisory Board of top industry professionals which will be helpful in identifying opportunities (including grants), building on the company's strengths, and serving as ambassadors to promote the products.

Safe Harbor Act

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company's website at www.usnuclearcorp.com

CONTACT:

US Nuclear Corp. (OTCQB:UCLE)
Robert I. Goldstein, President, CEO, and Chairman
Rachel Boulds, Chief Financial Officer
(818) 883 7043
Email: info@usnuclearcorp.com

SOURCE: US Nuclear Corp.

View source version on accesswire.com:
https://www.accesswire.com/631267/Modern-Military-Workforce-Athletes-and-Elderly-All-Need-Wearable-Chemosensors-to-Monitor-Safety-Health-and-Performance

FAQ

What is the partnership between US Nuclear Corp and Grapheton about?

US Nuclear Corp (OTCQB:UCLE) is collaborating with Grapheton to develop advanced wearable chemosensors for health monitoring.

What are the benefits of Grapheton’s chemosensors?

Grapheton's chemosensors offer longevity and resistance to corrosion, making them suitable for harsh environments.

How does the global chemical sensor market impact US Nuclear Corp (UCLE)?

The projected growth of the chemical sensor market to $30 billion by 2023 presents significant business opportunities for US Nuclear Corp.

What issues do Grapheton’s chemosensors aim to address?

These chemosensors aim to improve real-time health monitoring and workplace safety, reducing risks associated with various conditions.